Position in NVS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,245,453
+$77,527 QoQ
Shares Held
7,947
+3.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#567
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SAGE RHINO CAPITAL LLC holds $11,215,095 across 12 Drug Manufacturers - General names. NVS ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,014 | $2,415,652 | |
| 2 | JNJ |
Johnson & Johnson
|
6,868 | $1,744,265 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,448 | $1,342,568 | |
| 4 | NVS |
Novartis AG
This page
|
7,947 | $1,245,453 | |
| 5 | AZN |
Astrazeneca PLC
|
5,336 | $1,011,812 | |
| 6 | AMGN |
Amgen Inc
|
2,387 | $864,380 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
5,127 | $647,745 | |
| 8 | ABBV |
AbbVie Inc.
|
2,265 | $569,964 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,245,453 | 7,947 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,167,926 | 7,646 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,050,569 | 7,620 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,028,356 | 8,019 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $982,601 | 8,120 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $894,181 | 8,021 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $763,591 | 7,847 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $939,253 | 8,166 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $835,391 | 7,847 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $755,074 | 7,806 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $771,814 | 7,644 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $771,487 | 7,574 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $725,542 | 7,190 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $636,916 | 6,923 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $617,168 | 6,803 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $486,768 | 6,404 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $636,426 | 7,529 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $593,541 | 6,764 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $526,044 | 6,014 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $477,758 | 5,842 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $528,644 | 5,794 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $447,060 | 5,230 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $477,721 | 5,059 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $439,582 | 5,055 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $451,023 | 5,164 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $391,555 | 4,749 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||